Low molecular weight inhibitors of matrix metalloproteinases can enhance the expression of matrix metalloproteinase‐2 (gelatinase A) without inhibiting its activation
Open Access
- 3 March 2003
- Vol. 97 (6) , 1582-1588
- https://doi.org/10.1002/cncr.11193
Abstract
BACKGROUND In the current study, the authors investigated the effects of synthetic low molecular weight inhibitors of matrix metalloproteinases (MMPs) on the expression and activation of MMP-2 in a three-dimensional tissue system. METHODS Rabbit periosteal explants were cultured with or without various concentrations of the MMP inhibitors CT1166, CT1399, or CT1746, and conditioned media and tissue extracts were analyzed for the expression and activity of MMP-2. RESULTS The data showed that blocking the activity of all MMPs with relatively high inhibitor concentrations completely prevented the conversion of pro-MMP-2 into its active form and that the level of protein was decreased. Selective inhibition of the activity of gelatinases (MMP-2 and MMP-9) by using low inhibitor concentrations, however, induced a higher level of active MMP-2 and increased its expression significantly. CONCLUSIONS The current observations indicate that selective inhibitors of MMPs affect the expression and activity of MMP-2, thus providing clues regarding the differing effects such inhibitors appear to have when applied in vivo. Cancer 2003;97:1582–88. © 2003 American Cancer Society. DOI 10.1002/cncr.11193Keywords
This publication has 24 references indexed in Scilit:
- Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): a new aspect involving osteoclastic bone resorptionJournal of Bone and Mineral Metabolism, 2002
- Matrix Metalloproteinases-2 and 9 Do Not Play a Role in the Growth of Preneoplastic Liver Lesions in F344 RatsExperimental Biology and Medicine, 2001
- Effect of Matrix Metalloproteinase Inhibition on Pancreatic Cancer Invasion and MetastasisAnnals of Surgery, 2000
- Increased TIMP-1 activity results in increased expression of gelatinases and altered cell motilityJournal of Cellular Biochemistry, 1999
- Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in ratsCarcinogenesis: Integrative Cancer Research, 1999
- Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinomaInternational Journal of Cancer, 1999
- Matrix Metalloproteinase (MMP) Inhibition Selectively Decreases Type II MMP Activity in a Murine Model of Pancreatic CancerJournal of Surgical Research, 1999
- Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesisInternational Journal of Cancer, 1998
- Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenaseBiochemical Journal, 1995
- Tissue Inhibitor of Metalloproteinases (TIMP-1) Stimulates the Secretion of Collagenase from Human Skin FibroblastsBiochemical and Biophysical Research Communications, 1994